The use of regional coordinating centers in large clinical trials: the DIG trial

被引:9
|
作者
Collins, JE
Martin, S
Kent, E
Liuni, C
Garg, R
Egan, D
机构
[1] Cooperat Studies Program Coordinating Ctr, VA Maryland Hlth Care Syst, Dept Vet Affairs, Perry Point, MD 21902 USA
[2] Univ Maryland, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA
[3] Univ Alberta, Edmonton, AB, Canada
[4] St Josephs Hosp, Hamilton, ON, Canada
[5] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[6] Eli Lilly & Co, Indianapolis, IN 46285 USA
[7] NHLBI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA
来源
CONTROLLED CLINICAL TRIALS | 2003年 / 24卷 / 06期
关键词
randomized clinical trials; large simple trial; heart failure; digoxin; regional coordinating centers;
D O I
10.1016/S0197-2456(03)00101-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The Digitalis Investigation Group (DIG) trial was a large simple clinical trial that involved 302 participating centers in the United States and Canada. In order to encourage participation by Canadian investigators, to provide additional help to what were expected to be largely research-inexperienced investigators in Canada, and to provide the study's data coordinating center with resources in Canada to deal with potentially different rules, regulations, and cultural differences, regional coordinating centers were established in four regions of Canada: the maritime provinces, Quebec, Ontario, and western Canada. Canadian centers recruited significantly better than their U.S. counterparts and had slightly better retention and follow-up. While it is not possible to declare that the regional coordinating centers were responsible for this improvement, it is believed that these regional centers did play a role. This role included being able to identify investigators who could be expected to do well, providing one-on-one training and instruction to investigators, and being able to solve problems and implement change in the relatively fewer centers in their regions. The regional coordinating center also reduced the intensity of the workload on the data coordinating center by serving as the primary point of contact for Canadian investigators. The use of regional coordinating centers in studies with a large number of participating centers is highly recommended. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:298S / 305S
页数:8
相关论文
共 50 条
  • [31] Use of patient-reported outcomes in heart failure: from clinical trials to routine practice
    Savarese, Gianluigi
    Lindenfeld, Joann
    Stolfo, Davide
    Adams, Kirkwood
    Ahmad, Tariq
    Desai, Nihar R. R.
    Ammirati, Enrico
    Gottlieb, Stephen S. S.
    Psotka, Mitchell A. A.
    Rosano, Giuseppe M. C.
    Allen, Larry A. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (02) : 139 - 151
  • [32] Alpha tocopherol use in the management of diabetic cardiomyopathy: lessons learned from randomized clinical trials
    Celik, Turgay
    Yuksel, Cagdas
    Iyisoy, Atila
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2010, 24 (04) : 286 - 288
  • [33] Not-in-trial simulation I: Bridging cardiovascular risk from clinical trials to real-life conditions
    Chain, Anne S. Y.
    Dieleman, Jeanne P.
    van Noord, Charlotte
    Hofman, Albert
    Stricker, Bruno H. Ch
    Danhof, Meindert
    Sturkenboom, Miriam C. J. M.
    Della Pasqua, Oscar
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (06) : 964 - 972
  • [34] Inclusion of older women in randomized clinical trials: Factors associated with taking study medication in the fracture intervention trial
    Buist, DSM
    LaCroix, AZ
    Black, DM
    Harris, F
    Blank, J
    Ensrud, K
    Edgerton, D
    Rubin, S
    Fox, KM
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (09) : 1126 - 1131
  • [35] Covariate Adjustment in Heart Failure Randomized Controlled Clinical Trials: A Case Analysis of the HF-ACTION Trial
    O'Connor, Christopher M.
    Mentz, Robert J.
    Whellan, David J.
    HEART FAILURE CLINICS, 2011, 7 (04) : 497 - +
  • [36] Both clinical trial register and electronic bibliographic database searches were needed to identify randomized clinical trials for systematic reviews: an evaluation study
    Kaul, Tabea
    Colombijn, Julia M. T.
    Vernooij, Robin W. M.
    Spijker, Rene
    Idema, Demy L.
    In't Veld, Linde F. Huis
    Damen, Johanna A. A.
    Hooft, Lotty
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2024, 169
  • [37] Empagliflozin in the treatment of heart failure and type 2 diabetes mellitus: Evidence from several large clinical trials
    Liang, Bo
    Gu, Ning
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2022, 19 (07): : 1118 - 1121
  • [38] Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial
    Eisen, Alon
    Ruff, Christian T.
    Braunwald, Eugene
    Hamershock, Rose A.
    Lewis, Basil S.
    Hassager, Christian
    Chao, Tze-Fan
    Le Heuzey, Jean Yves
    Mercuri, Michele
    Rutman, Howard
    Antman, Elliott M.
    Giugliano, Robert P.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (07):
  • [39] Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data
    Speich, Benjamin
    von Niederhaeusern, Belinda
    Schur, Nadine
    Hemkens, Lars G.
    Fuerst, Thomas
    Bhatnagar, Neera
    Alturki, Reem
    Agarwal, Arnav
    Kasenda, Benjamin
    Pauli-Magnus, Christiane
    Schwenkglenks, Matthias
    Briel, Matthias
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2018, 96 : 1 - 11
  • [40] A reproducible framework for monitoring the impact of randomized clinical trials on clinical practice using large-scale real-world data: application to gynaecological surgical trials using the French national healthcare database
    Jochum, Floriane
    Doll, Madeleine
    Hamy, Anne-Sophie
    Donval, Lou
    Gougis, Paul
    Dumas, Elise
    Lecointre, Lise
    Gaillard, Thomas
    Reyal, Fabien
    Lecuru, Fabrice
    Akladios, Cherif
    Laas, Enora
    ECLINICALMEDICINE, 2025, 80